Quadrasep QMS

Soldiers are severely wounded in battle and a technology to put them on a road to recovery sounds like the need of the hour. In this view, scientists from IKOTECH LLC and Techshot based in the Purdue Research Park of Southeast Indiana have developed a technology that would seemingly aid soldiers regrow tissue and recover from acute wounds.

The technology namely, Quadrasep apparently enhances the collection of stem cells from adult adipose or fat tissue. This innovation will help separate certain stem cells from the gathered adipose tissue specimens. Better selectivity in stem cells enhances the results for subjects as the current techniques are restricted in their capacity to purify cells.

“Fat contains 10 times more stem cells than bone marrow. When they are transplanted, stem cells have the potential to dramatically improve the outcomes of patients with significant tissue loss, such as soldiers who suffer severe wounds,” commented Rich Boling, vice president of corporate advancement at Techshot.

Boling added that a mixture comprising stem cells and other kinds of cells could be purified from human fat. Varied structures of the human body such as cartilage, nerves, muscle and bone can be supposedly generated from the stem cells in the mixture.

IKOTECH will manage adaptation and commercialization of Quadrasep technology. Techshot will formulate and produce the new device which will be trialed by experts in the Adipose Stem Cell Center at the University of Pittsburgh’s McGowan Institute for Regenerative Medicine.

The main objective of this technology is to help soldiers who have undergone distraught and wounds. Additionally, it could also lead to development of new treatments for different conditions and disorders which will improve health and quality of life globally.